Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?

Annals of Surgery

Volumn 246, Issue 6, 2007, Pages 1075-1082

  Tonelli, Francesco ^a   Marcucci, Tommaso ^a   Fratini, Geri ^a   Tommasi, Maria Silvia ^a   Falchetti, Alberto ^a,b   Brandi, Maria Luisa ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Gastroenterology Unit Careggi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; HYPERPARATHYROIDISM; HYPOPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROID GLAND; PARATHYROIDECTOMY; PRIORITY JOURNAL; SURGICAL APPROACH; SURGICAL TECHNIQUE; THYMECTOMY;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 36549002670     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31811f4467     Document Type: Article

References (59)

1. Lee CH, Tseng LM, Chen JY, et al. Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates. Ann Surg Oncol. 2006;13:103-109.
2. Hubbard JGH, Sebag F, Maweja S, et al. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 2006;141:235-239.
3. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-5671.
4. Marx SJ. Multiple endocrine neoplasia type 1. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001:943-966.
5. Tramp D, Farren B, Wooding C, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med. 1996;89:653-669.
6. Skarulis MC. Clinical expressions of multiple endocrine neoplasia type 1 at the National Institutes of Health. Ann Intern Med. 1998;129:484-494.
7. Carling T, Udelsman R. Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med. 2005;257:27-37.
8. Elaraj DM, Skarulis MC, Libutti SK, et al. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery. 2003;134:858-865.
9. Wells SA, Pardon JR, Dale YK, et al. Long term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg. 1980;192:451-458.
10. Hellman P, Skogseid B, Juhlin C, et al. Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1. World J Surg. 1992;16:718-725.
11. Jansson S, Tisell LE. Total parathyroidectomy and parathyroid transplantation into subcutaneous fat tissue in the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Acta Chir Austriaca. 1994;26:23-26.
12. Marx SJ, Menczel J, Campbell G, et al. Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1. Clin Endocrinol. 1991;35:521-526.
13. Tommasi M, Brocchi A, Benucci A, et al. Intraoperative fall in plasma levels of intact parathyroid hormone in patients undergoing parathyroid adenomectomy. Int J Biol Markers. 1995;10:206-210.
14. Clark OH, Way LW, Hunt TW. Recurrent hyperparathyroidism. Ann Surg. 1976;184:391-401.
15. Brandi ML, Aurbach GD, Fitzpatrick LA. Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. N Engl J Med. 1986;314:1287-1289.
16. Kraimps JL, Quan-Yang D, Demeure M, et al. Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery. 1992;112:1080-1088.
17. Arnalsteen LC, Alesina PF, Quireux JL, et al. Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery. 2002;132:1119-1125.
18. Lairmore TC, Piersall LD, De Benedetti MK, et al. Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1. Ann Surg. 2004;239:637-645.
19. Metz DC, Jensen RT, Bale AE, et al. Multiple endocrine neoplasia type 1. In: Bile-zikian JP, Marcus R, Levine MA, eds. The Parathyroids. Basic and Clinical Concepts. New York: Raven Press; 1994:591-646.
20. Teh BT, Kytola S, Farnebo F, et al. Mutation analysis of the MEN 1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab. 1998;83:2621-2626.
21. Bassett JHD, Forbes SA, Pannett AAJ, et al. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet. 1998;62:232-244.
22. Mutch MG, Dilley WG, Sanjurjo F, et al. Germline mutations in the multiple endocrine neoplasia type 1 gene: evidence for frequent splicing defects. Hum Mutat. 1999;13:175-185.
23. Heppner C, Kester MB, Agarwal SK, et al. Somatic mutation of the MEN1 gene in parathyroid tumors. Nat Genet. 1997;16:375-378.
24. Thakker RV. Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am. 2000;29:541-562.
25. Courseaux A, Grosgeorge J, Gaudray P, et al. Definition of the minimal MEN 1 candidate area based on a 5-Mb integrated map of proximal 11q13. Genomics. 1996;37:354-365.
26. Hai N, Aoki N, Shimatsu A, et al. Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases without MEN 1. Clin Endocrinol (Oxf). 2000;52:509-518.
27. Ellard S, Hattersley AT, Brewer CM, et al. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing. Clin Endocrinol. 2005;62:169-175.
28. Guo SS, Sawicki MP. Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1. Mol Endocrinol. 2001;15:1653-1664.
29. Morelli A, Falchetti A, Martineti V, et al. MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1. Eur J Endocrinol. 2000;142:131-137.
30. Agarwal SK, Kester MB, Debelenko LV, et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet. 1997;6:1169-1175.
31. Cebrian A, Ruiz-Lorente S, Cascon A, et al. Mutational and gross deletion study of the MEN1 gene and correlation with clinical features in Spanish patients. J Med Genet. 2003;40:e72.
32. Kouvaraki MA, Lee JE, Shapiro SE, et al. Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Arch Surg. 2002;137:641-647.
33. Turner JJ, Leotlela PD, Pannett AA, et al. Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2002;87:2688-2693.
34. Wautot V, Vercherat C, Lespinasse J, et al. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phonotype and the functional domains of the MEN1 protein. Hum Mutat. 2002;20:35-47.
35. Amorosi A, Nesi G, Spini S, et al. Histologic features of parathyroid hyperplasia in multiple endocrine neoplasia type 1 (MEN-1). Diagnostic and surgical implications. Acta Chir Austriaca. 1994;26:13-15.
36. Wang CA. The anatomic basis of parathyroid surgery. Ann Surg. 1976;183:271-275.
37. Akerstrom G, Malmaeus J, Bergstrom R. Surgical anatomy of human parathyroid glands. Surgery. 1984;95:14-21.
38. Hellman P, Skogseid B, Oberg K, et al. Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery. 1998;124:993-999.
39. Burgess JR, David R, Greenaway TM, et al. Osteoporosis multiple endocrine neoplasia type 1. Arch Surg. 1999;134:1119-1123.
40. Tonelli F, Spini S, Tommasi MS, et al. Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type 1 syndrome and hyperparathyroidism. World J Surg. 2000;24:556-563.
41. Kivlen M, Bartlett DL, Libutti SK, et al. Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery. 2001;130:991-998.
42. O' Riordain DS, O' Brian T, Grant CS, et al. Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 and 2. Surgery. 1993;114:1031-1039.
43. Cougard P, Proye C. Hyperparathyroidism and multiple endocrine neoplasia type 1 (MEN-1). Acta Chir Austriaca. 1994;26:32-35.
44. Dralle H, Sheuemann GFW. How to handle the parathyroid glands in multiple endocrine neoplasia type 1 (MEN-1) and type 2 (MEN-2)? Surgical approach to uniglandular vs multiglandular disease in hereditary primary hyperparathyroidism. Acta Chir Austriaca. 1994;26:35-38.
45. Goudet P, Cougard P, Verges B, et al. Hyperparathyroidism in multiple endocrine neoplasia type 1: surgical trends and results of a 256-patient series from group d'etude des nèoplasies endocriniennes multiples study group. World J Surg. 2001;25:886-890.
46. Dotzenrath C, Cupisti K, Goretzki PE, et al. Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential? Eur J Surg. 2001;167:173-178.
47. Sokol MS, Kavolius J, Schaaf M, et al. Recurrent hyperparathyroidism from benign neoplastic seeding: a review with recommendations for management. Surgery. 1993;113:456-461.
48. Edis AJ, Van Heerden JA, Scholz DA. Results of sub-total parathyroidectomy for primary chief cell hyperplasia. Surgery. 1979;86:462-469.
49. Prinz RA, Gamvros OP, Sellu D, et al. Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type 1 syndrome. Surgery. 1981;193:26-29.
50. Van Heerden JA, Kent RB, Sizemore GW, et al. Primary hyperparathyroidism in patients with multiple endocrine neoplasia syndroms. Surgical experience. Arch Surg. 1983;118:533-536.
51. Goretzki PE, Dotzenrath C, Roeher HD. Management of primary hyperparathyroidism caused by multiglandular disease. World J Surg. 1991;15:693-697.
52. Thompson NW, Sandelin K. Technical considerations in the surgical management of primary hyperparathyroidism caused by multiple gland disease (hyperplasia). Acta Chir Austriaca. 1994;26:16-19.
53. Grant CS, Weaver A. Treatment of primary parathyroid hyperplasia: representative experience at Mayo Clinic. Acta Chir Austriaca. 1994;26:41-44.
54. Malmaeus J, Benson L, Johansson H, et al. Parathyroid surgery in the multiple endocrine neoplasia type 1 syndrome: choice of surgical procedure. World J Surg. 1986;10:668-672.
55. Lim LC, Tan MH, Eng C, et al. Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phonotype correlation and prevention. J Int Med. 2006;259:428-432.
56. Burgess JR, Giles N, Shepherd JJ. Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1. Clin Endocrinol. 2001;55:689-693.
57. Wagner PK, Seesko HG, Rothmund M. Replantation of cryopreserved human parathyroid tissue. World J Surg. 1991;15:751-755.
58. Edis AJ, Linos DA, Kao PC. Parathyroid autotransplantation to the time of reoperation for persistent hyperparathyroidism. Surgery. 1980;88:588-593.
59. Feldman AL, Sharaf RN, Skarulis MC, et al. Results of heterotopic parathyroid autotransplantation: a 13-year experience. Surgery. 1999;126:1042-1048.